All rights reserved.Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Stake and Stake Super are registered trademarks in Australia.Ĭopyright © 2022 Stake. Past performance of any product described on this website is not a reliable indication of future performance. All financial products involve risk and you should ensure you understand the risks involved as certain financial products may not be suitable to everyone. By using our website or service in any way, you agree to our Privacy Policy and Terms & Conditions. Please view our Financial Services Guide, Terms & Conditions, Privacy Policy and Disclaimers before deciding to invest on or use Stake or Stake Super. As investments carry risk, before making any investment decision, please consider if it’s right for you and seek appropriate taxation and legal advice. Any advice given by Stake is of a general nature only. At Stake and Stake Super, we’re focused on giving you a better investing experience but we don’t take into account your personal objectives, circumstances or financial needs. For more information about SMSFs, see our SMSF Risks page.The information on our website or our mobile application is not intended to be an inducement, offer or solicitation to anyone in any jurisdiction in which Stake is not regulated or able to market its services. Stakeshop Pty Ltd will also run marketing and promotions to you under. You will also be referred to Stakeshop Pty Ltd to enable your trading account and bank account to be set up in order to use the Stake Website and/or App. When you sign up to Stake Super, you are contracting with Stake SMSF Pty Ltd who will assist in the establishment of a SMSF under a ‘no advice model’. This specifically applies to any financial products which are established if you instruct Stake Super to set up a self managed super fund (‘SMSF’). Stake SMSF Pty Ltd (‘Stake Super’) is not licensed to provide financial product advice under the Corporations Act. Stake is not authorised by Sanlam under Sanlam’s AFSL to arrange for clients to be issued with a non-cash payment facility as Sanlam is not authorised under its AFSL for this purpose. Stake is not authorised by Airwallex under Airwallex’s AFSL to arrange for clients to be issued with securities as Airwallex is not authorised under its AFSL for this purpose. 1241398) of Airwallex Pty Ltd (Australian Financial Services Licence No. 337927) ('Sanlam') and an authorised representative (Authorised Representative No. 1241398) of Sanlam Private Wealth Pty Ltd (Australian Financial Services Licence No. Stakeshop Pty Ltd, trading as Stake, ACN 610105505, is an authorised representative (Authorised Representative No. In addition, Tablo also delivers robust clinical care.īuy US stocks in Australia with $0 brokerage and trade OM today! Tablo’s cloud connectivity software enables an ecosystem of machine diagnostics and analytics, treatment instruction, monitoring and reporting, improved documentation and remote machine management. Tablo’s touch screen panel enables the user to navigate through the treatment with animations and non-technical language, tailored to both professional and non-professional users. The Tablo cartridge is a single use consumable intended to facilitate extracorporeal blood purification for patients and consists of a pre-configured blood, saline, and infusion tubing. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels and allows providers to access a single platform from the hospital to the home. Tablo is a mobile integrated hemodialysis solution for acute and home hemodialysis therapy. is a medical technology company that offers Tablo.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |